{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T01:30:52Z","timestamp":1777426252735,"version":"3.51.4"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T00:00:00Z","timestamp":1586131200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T00:00:00Z","timestamp":1586131200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01 MH075025-03S2"],"award-info":[{"award-number":["R01 MH075025-03S2"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Lithium is a highly effective medication for bipolar disorder, but its mechanism of action remains unknown. In this study, brain MRI scans and blood samples for gene expression (total of 110 scans and 109 blood samples) were collected from 21 bipolar subjects before and after 2 and 8 weeks of lithium monotherapy and at the same time-points from untreated 16 healthy controls. We used linear mixed-effects models to identify brain structural features and genes with expression changed after lithium treatment, with correction for multiple testing, and correlated their concurrent changes to identify molecular pathways associated with lithium effects. There are significant increases in gray matter fraction, global cortical thickness, and the frontal and parietal cortices after 8 weeks of lithium treatment (corrected<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). Volume increases were also seen for putamen, hippocampus, thalamic nuclei, and thalamic substructures. Several genes showed significant expression changes, and 14 gene pathways were identified for the present integration analysis. Of these, nine pathways had significant correlations with structural changes (FDR\u2009&lt;\u20090.05). Three neurotrophy-related pathways (GDNF family of ligands, NFAT immune-response, and p53-signaling pathway) correlated with structural changes in multiple regions. Mediation analysis showed that the sphingomyelin metabolism pathway is associated with HAM-D change (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01), and this effect is mediated via the volume of mediodorsal thalamus (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.03). In summary, the integration of lithium effects on brain structural and peripheral gene expression changes revealed effects on several neurotrophic molecular pathways, which provides further insights into the mechanism of lithium action.<\/jats:p>","DOI":"10.1038\/s41398-020-0784-z","type":"journal-article","created":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T18:04:33Z","timestamp":1586196273000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Integrative analysis of lithium treatment associated effects on brain structure and peripheral gene expression reveals novel molecular insights into mechanism of action"],"prefix":"10.1038","volume":"10","author":[{"given":"Amit","family":"Anand","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunio","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8348-7157","authenticated-orcid":false,"given":"Jeffrey M.","family":"Spielberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jungwon","family":"Cha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harish","family":"Karne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,6]]},"reference":[{"key":"784_CR1","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0006-3223(99)00165-1","volume":"46","author":"HK Manji","year":"1999","unstructured":"Manji, H. K., Moore, G. J. & Chen, G. Lithium at 50: have the neuroprotective effects of this unique cation been overlooked? [Review]. Biol. Psychiatry 46, 929\u2013940 (1999).","journal-title":"Biol. Psychiatry"},{"key":"784_CR2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0893-133X(98)00022-0","volume":"19","author":"JC Soares","year":"1998","unstructured":"Soares, J. C. & Gershon, S. The lithium ion: a foundation for psychopharmacological specificity. Neuropsychopharmacology 19, 167\u2013182 (1998).","journal-title":"Neuropsychopharmacology"},{"key":"784_CR3","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1056\/NEJM199409013310907","volume":"331","author":"LH Price","year":"1994","unstructured":"Price, L. H. & Heninger, G. R. Lithium in the treatment of mood disorders. N. Engl. J. Med. 331, 591\u2013598 (1994).","journal-title":"N. Engl. J. Med."},{"key":"784_CR4","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1177\/0269881116636545","volume":"30","author":"G Goodwin","year":"2016","unstructured":"Goodwin, G. et al. Evidence-based guidelines for treating bipolar disorder: revised third edition recommendations from the British Association for Psychopharmacology. J. Psychopharmacol. 30, 495\u2013553 (2016).","journal-title":"J. Psychopharmacol."},{"key":"784_CR5","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1001\/archpsyc.1976.01770010073014","volume":"33","author":"DL Dunner","year":"1976","unstructured":"Dunner, D. L., Stallone, F. & Fieve, R. R. Lithium carbonate and affective disorders. V: a double-blind study of prophylaxis of depression in bipolar illness. Arch. Gen. Psychiatry 33, 117\u2013120 (1976).","journal-title":"Arch. Gen. Psychiatry"},{"key":"784_CR6","doi-asserted-by":"publisher","unstructured":"Cipriani, A., Hawton, K., Stockton, S. & Geddes J. R. Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis. BMJ 346, f3646 (2013). https:\/\/doi.org\/10.1136\/bmj.f3646","DOI":"10.1136\/bmj.f3646"},{"key":"784_CR7","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0893-133X(98)00021-9","volume":"19","author":"HK Manji","year":"1998","unstructured":"Manji, H. K. & Lenox, R. H. Lithium: a molecular transducer of mood-stabilization in the treatment of bipolar disorder. [Review] [42 refs]. Neuropsychopharmacology 19, 161\u2013166 (1998).","journal-title":"Neuropsychopharmacology"},{"key":"784_CR8","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/mp.2015.4","volume":"20","author":"M Alda","year":"2015","unstructured":"Alda, M. Lithium in the treatment of bipolar disorder: pharmacology and pharmacogenetics. Mol. Psychiatry 20, 661\u2013670 (2015).","journal-title":"Mol. Psychiatry"},{"key":"784_CR9","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/sj.mp.4001306","volume":"8","author":"RH Lenox","year":"0000","unstructured":"Lenox, R. H. & Wang, L. Molecular basis of lithium action: integration of lithium-responsive signaling and gene expression networks. Mol. Psychiatry 8, 135\u2013144 (0000).","journal-title":"Mol. Psychiatry"},{"issue":"Suppl. 2","key":"784_CR10","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1399-5618.2009.00714.x","volume":"11","author":"R Machado-Vieira","year":"2009","unstructured":"Machado-Vieira, R., Manji, H. K. & Zarate, C. A. Jr. The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis. Bipolar Disord. 11(Suppl. 2), 92\u2013109 (2009).","journal-title":"Bipolar Disord."},{"key":"784_CR11","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1038\/sj.npp.1301640","volume":"33","author":"U Boer","year":"2007","unstructured":"Boer, U. et al. Chronic lithium salt treatment reduces CRE\/\/CREB-directed gene transcription and reverses its upregulation by chronic psychosocial stress in transgenic reporter gene mice. Neuropsychopharmacology 33, 2407\u20132415 (2007).","journal-title":"Neuropsychopharmacology"},{"key":"784_CR12","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/00006842-199909000-00004","volume":"61","author":"G Chen","year":"1999","unstructured":"Chen, G. et al. Regulation of signal transduction pathways and gene expression by mood stabilizers and antidepressants. Psychosom. Med. 61, 599\u2013617 (1999).","journal-title":"Psychosom. Med."},{"key":"784_CR13","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.pnpbp.2004.01.009","volume":"28","author":"A Gladkevich","year":"2004","unstructured":"Gladkevich, A., Kauffman, H. F. & Korf, J. Lymphocytes as a neural probe: potential for studying psychiatric disorders. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 28, 559\u2013576 (2004).","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"784_CR14","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1177\/0333102416628463","volume":"36","author":"Z Gerring","year":"2016","unstructured":"Gerring, Z. et al. Blood gene expression studies in migraine: potential and caveats. Cephalalgia 36, 669\u2013678 (2016).","journal-title":"Cephalalgia"},{"key":"784_CR15","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1126\/science.aaa0355","volume":"348","author":"M Mele","year":"2015","unstructured":"Mele, M. et al. Human genomics. The human transcriptome across tissues and individuals. Science (New York, NY) 348, 660\u2013665 (2015).","journal-title":"Science (New York, NY)"},{"key":"784_CR16","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/ajmg.b.30272","volume":"141B","author":"PF Sullivan","year":"2006","unstructured":"Sullivan, P. F., Fan, C. & Perou, C. M. Evaluating the comparability of gene expression in blood and brain. Am. J. Med. Genet. Part B 141B, 261\u2013268 (2006).","journal-title":"Am. J. Med. Genet. Part B"},{"key":"784_CR17","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/ajmg.b.31062","volume":"153B","author":"B Rollins","year":"2010","unstructured":"Rollins, B., Martin, M. V., Morgan, L. & Vawter, M. P. Analysis of whole genome biomarker expression in blood and brain. Am. J. Med. Genet. Part B 153B, 919\u2013936 (2010).","journal-title":"Am. J. Med. Genet. Part B"},{"key":"784_CR18","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/mp.2008.11","volume":"14","author":"H Le-Niculescu","year":"2009","unstructured":"Le-Niculescu, H. et al. Identifying blood biomarkers for mood disorders using convergent functional genomics. Mol. Psychiatry 14, 156\u2013174 (2009).","journal-title":"Mol. Psychiatry"},{"key":"784_CR19","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1038\/mp.2013.95","volume":"18","author":"H Le-Niculescu","year":"2013","unstructured":"Le-Niculescu, H. et al. Discovery and validation of blood biomarkers for suicidality. Mol. Psychiatry 18, 1249\u20131264 (2013).","journal-title":"Mol. Psychiatry"},{"key":"784_CR20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/2045-5380-2-15","volume":"2","author":"L Lowthert","year":"2012","unstructured":"Lowthert, L. et al. Increased ratio of anti-apoptotic to pro-apoptotic Bcl2 gene-family members in lithium-responders one month after treatment initiation. Biol. Mood Anxiety Disord. 2, 15\u201315 (2012).","journal-title":"Biol. Mood Anxiety Disord."},{"key":"784_CR21","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/tpj.2013.16","volume":"14","author":"RD Beech","year":"2014","unstructured":"Beech, R. D. et al. Gene-expression differences in peripheral blood between lithium responders and non-responders in the Lithium Treatment-Moderate dose Use Study (LiTMUS). Pharmacogenom. J. 14, 182\u2013191 (2014).","journal-title":"Pharmacogenom. J."},{"key":"784_CR22","first-page":"115","volume":"2","author":"A Anand","year":"2016","unstructured":"Anand, A. et al. Effects of lithium monotherapy for bipolar disorder on gene expression in peripheral lymphocytes. Mol. Neuropsychiatry 2, 115\u2013123 (2016).","journal-title":"Mol. Neuropsychiatry"},{"key":"784_CR23","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1001\/archpsyc.65.9.1017","volume":"65","author":"MJ Kempton","year":"2008","unstructured":"Kempton, M. J., Geddes, J. R., Ettinger, U., Williams, S. R. & Grasby, P. M. MEta-analysis database, and meta-regression of 98 structural imaging studies in bipolar disorder. Arch. Gen. Psychiatry 65, 1017\u20131032 (2008).","journal-title":"Arch. Gen. Psychiatry"},{"key":"784_CR24","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.biopsych.2004.06.021","volume":"56","author":"C McDonald","year":"2004","unstructured":"McDonald, C. et al. Meta-analysis of magnetic resonance imaging brain morphometry studies in bipolar disorder. Biol. Psychiatry 56, 411\u2013417 (2004).","journal-title":"Biol. Psychiatry"},{"key":"784_CR25","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.biopsych.2010.08.029","volume":"69","author":"B Hallahan","year":"2011","unstructured":"Hallahan, B. et al. Structural magnetic resonance imaging in bipolar disorder: an international collaborative mega-analysis of individual adult patient data. Biol. Psychiatry 69, 326\u2013335 (2011).","journal-title":"Biol. Psychiatry"},{"key":"784_CR26","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/S0140-6736(00)02793-8","volume":"356","author":"GJ Moore","year":"2000","unstructured":"Moore, G. J., Bebchuk, J. M., Wilds, I. B., Chen, G. & Menji, H. K. Lithium-induced increase in human brain grey matter. Lancet 356, 1241\u20131242 (2000).","journal-title":"Lancet"},{"key":"784_CR27","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1038\/npp.2010.41","volume":"35","author":"IK Lyoo","year":"2010","unstructured":"Lyoo, I. K. et al. Lithium-induced gray matter volume increase as a neural correlate of treatment response in bipolar disorder: a Longitudinal Brain Imaging Study. Neuropsychopharmacology 35, 1743\u20131750 (2010).","journal-title":"Neuropsychopharmacology"},{"key":"784_CR28","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jad.2013.04.020","volume":"150","author":"S Selek","year":"2013","unstructured":"Selek, S. et al. A longitudinal study of fronto-limbic brain structures in patients with bipolar I disorder during lithium treatment. J. Affect. Disord. 150, 629\u2013633 (2013).","journal-title":"J. Affect. Disord."},{"key":"784_CR29","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2174\/1570159X13666150403231654","volume":"13","author":"C McDonald","year":"2015","unstructured":"McDonald, C. Brain structural effects of psychopharmacological treatment in bipolar disorder. Curr. Neuropharmacol. 13, 445\u2013457 (2015).","journal-title":"Curr. Neuropharmacol."},{"key":"784_CR30","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual 4th edn\u2014Text Revision (DSM-IV-TR) (American Psychiatric Association, Washington, 2000)."},{"key":"784_CR31","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","volume":"133","author":"RC Young","year":"1978","unstructured":"Young, R. C., Biggs, J. T., Ziegler, V. E. & Meyer, D. A. A rating scale for mania: reliability, validity and sensitivity. Br. J. Psychiatry 133, 429\u2013435 (1978).","journal-title":"Br. J. Psychiatry"},{"key":"784_CR32","first-page":"28","volume":"4","author":"J Busner","year":"2007","unstructured":"Busner, J. & Targum, S. D. The clinical global impressions scale: applying a research tool in clinical practice. Psychiatry (Edgmont) 4, 28\u201337 (2007).","journal-title":"Psychiatry (Edgmont)"},{"key":"784_CR33","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1109\/42.668698","volume":"17","author":"JG Sled","year":"1998","unstructured":"Sled, J. G., Zijdenbos, A. P. & Evans, A. C. A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans. Med. Imag. 17, 87\u201397 (1998).","journal-title":"IEEE Trans. Med. Imag."},{"issue":"2, Part A","key":"784_CR34","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/nimg.1995.1012","volume":"2","author":"JC Mazziotta","year":"1995","unstructured":"Mazziotta, J. C., Toga, A. W., Evans, A., Fox, P. & Lancaster, J. A probabilistic atlas of the human brain: theory and rationale for its development: The International Consortium for Brain Mapping (ICBM). NeuroImage 2(2, Part A), 89\u2013101 (1995).","journal-title":"NeuroImage"},{"key":"784_CR35","unstructured":"Nakamura, K. MRI Analysis to Detect Gray Matter Tissue Loss in Multiple Sclerosis. Ph.D. thesis, Case Western Reserve University (2011)."},{"key":"784_CR36","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/00004728-199403000-00005","volume":"18","author":"DL Collins","year":"1994","unstructured":"Collins, D. L., Neelin, P., Peters, T. M. & Evans, A. C. Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space. J. Comput. Assist. Tomogr. 18, 192\u2013205 (1994).","journal-title":"J. Comput. Assist. Tomogr."},{"key":"784_CR37","first-page":"197","volume":"6","author":"J Ashburner","year":"2012","unstructured":"Ashburner, J. & Ridgway, G. R. Symmetric diffeomorphic modeling of longitudinal structural MRI. Front. Neurosci. 6, 197 (2012).","journal-title":"Front. Neurosci."},{"key":"784_CR38","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.neuroimage.2010.07.052","volume":"54","author":"K Nakamura","year":"2011","unstructured":"Nakamura, K., Fox, R. & Fisher, E. CLADA: cortical longitudinal atrophy detection algorithm. Neuroimage 54, 278\u2013289 (2011).","journal-title":"Neuroimage"},{"key":"784_CR39","unstructured":"Patenaude, B., Smith, S., Kennedy, D. & Jenkinson, M. Bayesian shape and appearance models. University of Oxford (2007)."},{"key":"784_CR40","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.nicl.2013.10.015","volume":"4","author":"K Nakamura","year":"2014","unstructured":"Nakamura, K. et al. Jacobian integration method increases the statistical power to measure gray matter atrophy in multiple sclerosis. NeuroImage: Clin. 4, 10\u201317 (2014).","journal-title":"NeuroImage: Clin."},{"key":"784_CR41","doi-asserted-by":"crossref","unstructured":"Tingley, D., Yamamoto, T., Hirose, K., Keele, L. & Imai, K. Mediation: R package for causal mediation analysis. J. Stat. Softw. 59, (2014).","DOI":"10.18637\/jss.v059.i05"},{"key":"784_CR42","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.pscychresns.2008.03.012","volume":"171","author":"A Anand","year":"2009","unstructured":"Anand, A., Li, Y., Wang, Y., Lowe, M. J. & Dzemidzic, M. Resting state corticolimbic connectivity abnormalities in unmedicated bipolar disorder and unipolar depression. Psychiatry Res.-Neuroimaging 171, 189\u2013198 (2009).","journal-title":"Psychiatry Res.-Neuroimaging"},{"key":"784_CR43","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.biopsych.2005.02.021","volume":"15","author":"A Anand","year":"2005","unstructured":"Anand, A. et al. Activity and connectivity of mood regulating circuit in depression: a functional magnetic resonance study. Biol. Psychiatry 15, 1079\u20131088 (2005).","journal-title":"Biol. Psychiatry"},{"key":"784_CR44","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1749-6632.2003.tb07095.x","volume":"985","author":"A Anand","year":"2003","unstructured":"Anand, A. & Shekhar, A. Brain imaging studies in mood and anxiety disorders: special emphasis on the amygdala. Ann. N. Y. Acad. Sci. 985, 370\u2013388 (2003).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"784_CR45","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1089\/brain.2015.0396","volume":"6","author":"MI Altinay","year":"2016","unstructured":"Altinay, M. I., Hulvershorn, L. A., Karne, H., Beall, E. B. & Anand, A. Differential Resting-State Functional Connectivity of Striatal Subregions in Bipolar Depression and Hypomania. Brain connect. 6, 255\u2013265 (2016).","journal-title":"Brain connect"},{"key":"784_CR46","doi-asserted-by":"crossref","first-page":"11825","DOI":"10.1523\/JNEUROSCI.3463-08.2008","volume":"28","author":"O Hikosaka","year":"2008","unstructured":"Hikosaka, O., Sesack, S. R., Lecourtier, L. & Shepard, P. D. Habenula: crossroad between the basal ganglia and the limbic system. J. Neurosci. 28, 11825\u201311829 (2008).","journal-title":"J. Neurosci."},{"key":"784_CR47","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nature25509","volume":"554","author":"Y Yang","year":"2018","unstructured":"Yang, Y. et al. Ketamine blocks bursting in the lateral habenula to rapidly relieve depression. Nature 554, 317 (2018).","journal-title":"Nature"},{"key":"784_CR48","doi-asserted-by":"crossref","first-page":"5141","DOI":"10.1523\/JNEUROSCI.23-12-05141.2003","volume":"23","author":"TF Oo","year":"2003","unstructured":"Oo, T. F., Kholodilov, N. & Burke, R. E. Regulation of natural cell death in dopaminergic neurons of the substantia nigra by striatal glial cell line-derived neurotrophic factor in vivo. J. Neurosci. 23, 5141\u20135148 (2003).","journal-title":"J. Neurosci."},{"key":"784_CR49","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nm850","volume":"9","author":"SS Gill","year":"2003","unstructured":"Gill, S. S. et al. Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat. Med. 9, 589\u2013595 (2003).","journal-title":"Nat. Med."},{"key":"784_CR50","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ijdevneu.2007.10.004","volume":"26","author":"T Nguyen","year":"2008","unstructured":"Nguyen, T. & Di Giovanni, S. NFAT signaling in neural development and axon growth. Int. J. Dev. Neurosci. 26, 141\u2013145 (2008).","journal-title":"Int. J. Dev. Neurosci."},{"key":"784_CR51","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/B978-0-12-398309-1.00005-6","volume":"105","author":"G Quadrato","year":"2012","unstructured":"Quadrato, G. & Di Giovanni, S. Gatekeeper between quiescence and differentiation: p53 in axonal outgrowth and neurogenesis. Int. Rev. Neurobiol. 105, 71\u201389 (2012).","journal-title":"Int. Rev. Neurobiol."},{"key":"784_CR52","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000442603","volume":"23","author":"PL Jernigan","year":"2015","unstructured":"Jernigan, P. L. et al. Sphingolipids in major depression. Neuro-Signals 23, 49\u201358 (2015).","journal-title":"Neuro-Signals"},{"key":"784_CR53","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/jnc.13145","volume":"134","author":"E Gulbins","year":"2015","unstructured":"Gulbins, E. et al. A central role for the acid sphingomyelinase\/ceramide system in neurogenesis and major depression. J. Neurochem. 134, 183\u2013192 (2015).","journal-title":"J. Neurochem."}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-020-0784-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-020-0784-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-020-0784-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T14:32:15Z","timestamp":1722695535000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-020-0784-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,6]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["784"],"URL":"https:\/\/doi.org\/10.1038\/s41398-020-0784-z","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,6]]},"assertion":[{"value":"30 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This manuscript contains content that is the subject of a pending United States Patent application 16\/413,896. Authors report no other competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"103"}}